COVID-19 Vaccinations in Trial Participants: Should this happen or not?

Webinar - Free Q&A Session

Description

Event Webinar
Type Virtual Event
Language English
Date(s) 15 Feb. 2021
Day(s) 17:00 - 18:00
Duration 1 hour

Our Free of Charge weekly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.

COVID-19 Vaccinations in Trial Participants: Should this happen or not?

Programme

17:00 Opening of the Webinar Mark Poulton, Poulton Quality Solutions
Introduction
Heather Sampson, University of Toronto
Ethical and Methodological Considerations
Beat Widler, WS QMS
What are the problems when a trial participant is given the opportunity to be given an approved vaccine?
Seif Eddine Amara Madi, GSK
Panel Discussion: What are the problems when a trial participant is given the opportunity to participate in a COVID-19 vaccine clinical trial?
Cathy Dove, Dove Quality Solutions
David Haerry, Patvocates
Louise Mawer, Mirabilitas
Sarah Hall, Mipsol Ltd
Sylvia Kranich, SK Consulting
18:00 End of the Webinar